DRIO — DarioHealth Cashflow Statement
0.000.00%
Last trade - 00:00- $31.18m
- $31.46m
- $27.04m
- 40
- 63
- 38
- 44
Annual cashflow statement for DarioHealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -29.4 | -76.8 | -62.2 | -59.4 | -42.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 11.4 | 26.3 | 20.1 | 20.2 | 0.135 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.15 | -3.29 | -10.5 | 3.83 | -3.38 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -17.7 | -50.4 | -47.8 | -30.4 | -38.6 |
| Capital Expenditures | -0.118 | -0.261 | -0.573 | -0.584 | -0.138 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.5 | -7.87 | 0 | 0.037 | -8.8 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.62 | -8.13 | -0.573 | -0.547 | -8.93 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 27.5 | 65.8 | 61.9 | 18.3 | 38.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.19 | 7.22 | 13.5 | -12.7 | -9.03 |